Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro, Francesca Fagiani, Marco Racchi, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 599

Showing 26-50 of 599 citing articles:

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Pérez-Jeldres, Manuel Álvarez-Lobos, Jesús Rivera–Nieves
Drugs (2021) Vol. 81, Iss. 9, pp. 985-1002
Open Access | Times Cited: 148
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wenbing Wu, Ying Cheng, Hong Zhou, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 145
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 143
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
Elnaz Roohi, Nématollah Jaafari, Farshad Hashemian
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 142
Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
Ruirong Chen, Zhien Lan, Jujian Ye, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 141
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19
Davide Scozzi, Marlene Cano, Lina Ma, et al.
JCI Insight (2021)
Open Access | Times Cited: 140
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
Moumita Manik, Rakesh Kumar Singh
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 869-877
Open Access | Times Cited: 139
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Nina Kreuzberger, Caroline Hirsch, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 9
Open Access | Times Cited: 134
Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study
Joël Pincemaïl, Étienne Cavalier, Corinne Charlier, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 257-257
Open Access | Times Cited: 122
The Role of Th17 Response in COVID-19
Diana Martonik, Anna Parfieniuk‐Kowerda, Magdalena Rogalska, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1550-1550
Open Access | Times Cited: 117
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
Gihanna Galindez, Julian Matschinske, Tim Rose, et al.
Nature Computational Science (2021) Vol. 1, Iss. 1, pp. 33-41
Open Access | Times Cited: 114
Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies
Jiahui Chen, Kaifu Gao, Rui Wang, et al.
Chemical Science (2021) Vol. 12, Iss. 20, pp. 6929-6948
Open Access | Times Cited: 114
Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
Farzan Vahedifard, Krishnan Chakravarthy
Emergent Materials (2021) Vol. 4, Iss. 1, pp. 75-99
Open Access | Times Cited: 113
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients
Matthieu Perreau, Madeleine Suffiotti, Pedro Marques‐Vidal, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 106
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
Georg Jocher, Vincent Grass, Sarah K. Tschirner, et al.
EMBO Reports (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 102
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy
Chao Fang, Gaozhe Xiao, Taixia Wang, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 62
Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules
Kieran D. Lamb, Martha M. Luka, Megan Saathoff, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011795-e1011795
Open Access | Times Cited: 17
The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease
Ritu Pasrija, Mohammad Naime
International Immunopharmacology (2020) Vol. 90, pp. 107225-107225
Open Access | Times Cited: 104
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
Fabrizio Cantini, Delia Goletti, Linda Petrone, et al.
Drugs (2020) Vol. 80, Iss. 18, pp. 1929-1946
Open Access | Times Cited: 102
SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants
Surabhi Srivastava, Sofia Banu, Priya Singh, et al.
Journal of Biosciences (2021) Vol. 46, Iss. 1
Open Access | Times Cited: 102
Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model
Acharya Balkrishna, Subarna Pokhrel, Hoshiyar Singh, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 1111-1133
Open Access | Times Cited: 98
COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics?
Wim Van Damme, Ritwik Dahake, Remco van de Pas, et al.
Medical Hypotheses (2020) Vol. 146, pp. 110431-110431
Open Access | Times Cited: 96
Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19
Jayanta Talukdar, Bhaskar Bhadra, Tomal Dattaroy, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110886-110886
Open Access | Times Cited: 93

Scroll to top